Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-03-18 4:46 pm Purchase | 13D | ELIEM THERAPEUTICS INC ELYM | RA CAPITAL MANAGEMENT L.P. | 13,179,181 47.5% | 2,778 (+0.02%) | View |
2024-02-07 11:53 am Purchase | 13G | ELIEM THERAPEUTICS INC ELYM | BML Investment Partners L.P. | 2,350,682 8.5% | 453,068 (+23.88%) | View |
2023-11-17 4:30 pm Purchase | 13D | ELIEM THERAPEUTICS INC ELYM | RA CAPITAL MANAGEMENT L.P. | 13,176,403 47.7% | 13,332 (+0.10%) | View |
2023-11-13 5:13 pm Unchanged | 13D | ELIEM THERAPEUTICS INC ELYM | AI ETI LLC | 5,009,400 18.5% | 0 (Unchanged) | View |
2023-04-10 5:01 pm Purchase | 13D | ELIEM THERAPEUTICS INC ELYM | RA CAPITAL MANAGEMENT L.P. | 13,163,071 48.8% | 11,112 (+0.08%) | View |
2023-03-08 4:00 pm Purchase | 13G | ELIEM THERAPEUTICS INC ELYM | Intermediate Capital Group plc | 2,002,563 7.5% | 2,002,563 (New Position) | View |
2023-02-14 2:22 pm Sale | 13G | ELIEM THERAPEUTICS INC ELYM | SAMLYN CAPITAL LLC | 0 0% | -2,128,202 (Position Closed) | View |
2023-02-08 4:35 pm Purchase | 13G | ELIEM THERAPEUTICS INC ELYM | BML Investment Partners L.P. | 1,897,614 7.1% | 158,236 (+9.10%) | View |
2022-09-22 5:02 pm Purchase | 13G | ELIEM THERAPEUTICS INC ELYM | ICG Life Sciences SCSp | 2,002,563 7.5% | 2,002,563 (New Position) | View |
2022-05-04 11:25 am Purchase | 13G | ELIEM THERAPEUTICS INC ELYM | BML Investment Partners L.P. | 1,739,378 6.5% | 1,739,378 (New Position) | View |
2022-04-04 5:12 pm Purchase | 13G | ELIEM THERAPEUTICS INC ELYM | SAMLYN CAPITAL LLC | 2,128,202 8% | 424,656 (+24.93%) | View |
2022-02-14 1:42 pm Purchase | 13G | ELIEM THERAPEUTICS INC ELYM | SAMLYN CAPITAL LLC | 1,703,546 6.4% | 1,703,546 (New Position) | View |
2021-08-23 3:52 pm Purchase | 13D | ELIEM THERAPEUTICS INC ELYM | AI ETI LLC | 5,009,400 19.8% | 5,009,400 (New Position) | View |
2021-08-19 4:30 pm Purchase | 13D | ELIEM THERAPEUTICS INC ELYM | RA CAPITAL MANAGEMENT L.P. | 13,151,959 50% | 13,151,959 (New Position) | View |